Isfahan University of Medical Sciences Reports Findings in Tuberous Sclerosis (Efficacy and Safety of Topical Timolol for the Treatment of Facial Angiofibroma in Children with Tuberous Sclerosis Complex).

MLA

“Isfahan University of Medical Sciences Reports Findings in Tuberous Sclerosis (Efficacy and Safety of Topical Timolol for the Treatment of Facial Angiofibroma in Children with Tuberous Sclerosis Complex).” Pediatrics Week, Dec. 2023, p. 264. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=173753674&authtype=sso&custid=ns315887.

APA

Isfahan University of Medical Sciences Reports Findings in Tuberous Sclerosis (Efficacy and Safety of Topical Timolol for the Treatment of Facial Angiofibroma in Children with Tuberous Sclerosis Complex). (2023). Pediatrics Week, 264.

Chicago

“Isfahan University of Medical Sciences Reports Findings in Tuberous Sclerosis (Efficacy and Safety of Topical Timolol for the Treatment of Facial Angiofibroma in Children with Tuberous Sclerosis Complex).” 2023. Pediatrics Week, December, 264. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=173753674&authtype=sso&custid=ns315887.